✦ LIBER ✦

Presumptive diagnosis of malaria in infants in an endemic area

✍ Scribed by A. Sowunmi; J.A. Akindele

Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 112 KB
Volume: 87
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(93)90022-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of benzothiocarboxypurine for

Evaluation of benzothiocarboxypurine for malaria diagnosis in an endemic area

✍ A.Hunt Cooke; S. Morris-Jones; J. Horton; B.M. Greenwood; A.H. Moody; P.L. Chiod 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Malaria during pregnancy in an area of u

Malaria during pregnancy in an area of unstable endemicity

✍ F. Nosten; F. ter Kuile; L. Maelankirri; B. Decludt; N.J. White 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 868 KB

Misdiagnosis of cerebral malaria in adol

Misdiagnosis of cerebral malaria in adolescents and adults in an endemic area

✍ A. Sowunmi 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Presumptive diagnosis of malaria results

Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel

✍ Michael Olivar; Michel Develoux; Ari Chegou Abari; Louis Loutan 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 213 KB

A longitudinal study of splenomegaly in

A longitudinal study of splenomegaly in pregnancy in a malaria endemic area in Papua New Guinea

✍ B.J. Brabin; L.R. Brabin; J. Sapau; M.P. Alpers 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 595 KB

Hepatitis B vaccine in infants from an e

Hepatitis B vaccine in infants from an endemic area: Long-term anti-HBs persistence and revaccination

✍ B. Yvonnet; P. Coursaget; J. Chotard; M. Sarr; R. Ndoye; J. P. Chiron; I. Diop-M 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Persistence of anti-HBs in 156 Senegalese infants immunized with hepatitis B vaccine was studied for periods ranging from 2 to 6 years after booster dose administration. Six years after the booster dose, 90.4% of the infants had detectable anti-HBs antibodies, with 78.1% having titers higher than 10